Clincosm LogoSign in Get a demo

primary immunodeficiency

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Immunodeficiency Trial in Ankara (Inspiratory muscle training, Upper extremity aerobic exercise training, Lower

Not yet recruiting
  • Primary Immunodeficiency
  • Inspiratory muscle training
  • +4 more
  • Ankara, Çankaya, Turkey
    Gazi University, Faculty of Health Sciences, Department of Physi
Oct 14, 2023

Fibroblast-Derived Cell Lines From Skin Biopsies of

Enrolling by invitation
  • Primary Immunodeficiency
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 18, 2023

    NIAID Centralized Sequencing Protocol

    Recruiting
    • Atopy
    • +3 more
      • Washington, District of Columbia
      • +1 more
      Jan 12, 2023

      Immune-mediated Diseases

      Recruiting
      • Primary Immunodeficiency
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 10, 2023

        Primary Immunodeficiency Trial in United States (IGSC 20%)

        Completed
        • Primary Immunodeficiency
        • IGSC 20%
        • Birmingham, Alabama
        • +11 more
        Nov 2, 2022

        Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in Graz (potential biomarkers)

        Recruiting
        • Immune Thrombocytopenia
        • +3 more
        • potential biomarkers
        • Graz, Styria, Austria
          Pediatric Hematology-Oncology Outpatient Clinic
        Sep 8, 2022

        Primary Immunodeficiency Trial in United States (Gamunex-C, IVIG-PEG)

        Completed
        • Primary Immunodeficiency
        • Gamunex-C
        • IVIG-PEG
        • Birmingham, Alabama
        • +10 more
        Jun 7, 2022

        Outcomes Study (FIGARO)

        Completed
        • Primary Immunodeficiency
        • Secondary Immune Deficiency
        • HyQvia
        • Paris, France
        • +3 more
        Mar 18, 2022

        Primary Immunodeficiency Trial in United States (Immune Globulin Intravenous, Prometic's Immune Globulin Intravenous 10%)

        Completed
        Has Results
        • Primary Immunodeficiency
        • Immune Globulin Intravenous
        • Prometic's Immune Globulin Intravenous 10%
        • Irvine, California
        • +12 more
        Nov 3, 2021

        Primary Immunodeficiencies in Patients Hospitalized for Severe

        Recruiting
        • Primary Immunodeficiency
          • Montpellier, France
            Uhmontpellier
          Oct 11, 2021

          Primary Immunodeficiency, PID Trial in Pittsburgh (CD3/CD19 neg allogeneic BMT)

          Active, not recruiting
          • Primary Immunodeficiency
          • PID
          • CD3/CD19 neg allogeneic BMT
          • Pittsburgh, Pennsylvania
            Children's Hospital of Pittsburgh of University of Pittsburgh Me
          Oct 6, 2021

          Prognosis and Therapeutic Decision Tool for Autoimmunity and

          Not yet recruiting
          • Autoimmune Lymphoproliferative Syndrome
          • +19 more
          • Collection of samples
          • (no location specified)
          May 26, 2021

          Primary Immunodeficiency, Agammaglobulinemia, Hypogammaglobulinemia Trial in Canada, United States (Kedrion IVIG 10%)

          Completed
          Has Results
          • Primary Immunodeficiency
          • +3 more
          • Kedrion IVIG 10%
          • Little Rock, Arkansas
          • +14 more
          Jan 29, 2021

          COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy

          Unknown status
          • Allogenic Hematopoietic Cell Transplant
          • +2 more
            • Tel-Aviv, Israel
              Tel-Aviv Sourasky Medical Center
            Jan 27, 2021

            Primary Immunodeficiency Trial in Canada, United States (Octanorm 16.5%)

            Completed
            Has Results
            • Primary Immunodeficiency
            • Octanorm 16.5%
            • Irvine, California
            • +6 more
            Oct 2, 2020

            Primary Immunodeficiency Trial in Worldwide (IGSC 20%)

            Completed
            Has Results
            • Primary Immunodeficiency
            • IGSC 20%
            • Auchenflower, Australia
            • +22 more
            Jun 12, 2020

            Primary Immunodeficiency Trial in Assiut (minipooled- Intravenous immunoglobulin(MP-IVIG))

            Completed
            • Primary Immunodeficiency
            • minipooled- Intravenous immunoglobulin(MP-IVIG)
            • Assiut, Egypt
              Faculty of Medicine
            May 10, 2020

            Primary Immunodeficiency Trial in United States (IGSC 20% daily push versus every 2 weeks pump, IGSC 20% daily push versus once

            Withdrawn
            • Primary Immunodeficiency
            • IGSC 20% daily push versus every 2 weeks pump
            • +3 more
            • South Bend, Indiana
            • +3 more
            Apr 8, 2020

            Primary Immunodeficiency Trial in Canada, United States (IgPro20)

            Completed
            Has Results
            • Primary Immunodeficiency
            • Birmingham, Alabama
            • +11 more
            Mar 16, 2020

            Primary Immunodeficiency Trial in Canada, United States (IGIV-C 10%, IGSC 20%)

            Completed
            Has Results
            • Primary Immunodeficiency
            • IGIV-C 10%
            • IGSC 20%
            • Los Angeles, California
            • +24 more
            Sep 13, 2019

            Primary Immunodeficiency Trial in France (IgHy10)

            Completed
            • Primary Immunodeficiency
            • Lille, France
            • +6 more
            Jun 24, 2019

            Primary Immunodeficiency Trial in Worldwide (Chrono Super PID then Generic Syringe-Gammanorm, Generic Syringe then Chrono Super

            Completed
            • Primary Immunodeficiency
            • Chrono Super PID then Generic Syringe-Gammanorm
            • Generic Syringe then Chrono Super PID-Gammanorm
            • Campbelltown, Australia
            • +11 more
            Apr 5, 2019

            The Benefit of 5% IVIG for Primary Immunodeficiency Disorders

            Completed
            • Primary Immunodeficiency
              • (no location specified)
              Nov 7, 2017

              Primary Immunodeficiency Trial in Bangkok (Verorab® (PVRV; Purified Vero Cell Vaccine))

              Unknown status
              • Primary Immunodeficiency
              • Verorab® (PVRV; Purified Vero Cell Vaccine)
              • Bangkok, Thailand
                Division of Allergic and Immunology , Department of Pediatrics,
              Jul 2, 2015

              Primary Immunodeficiency Trial in Westminster (Gadolinium For abdomen, Gadolinium For lower back, Efficacy of Gammagard

              Unknown status
              • Primary Immunodeficiency
              • Gadolinium For abdomen
              • +13 more
              • Westminster, California
                Automatic Subdermal Injector System, Inc
              Jun 22, 2015